Related Experiment Videos
Recurrent pleural effusion as manifesting feature of primitive chest wall Hodgkin's disease
P Bernardeschi1, I Bonechi, U Urbano
1Divisione de Medicina Interna, Ospedale di S. Miniato, Italy.
Chest
|August 1, 1988
Abstract:
Recurrent, cytologically benign pleural effusion was, for a long time, the only clinical manifestation of Hodgkin's disease involving the inner thoracic wall in the reported case. It is the first case reported in literature.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Targeted-therapy in advanced renal cell carcinoma.
Current medicinal chemistry·2011
Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study.
In vivo (Athens, Greece)·2007
Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.
Journal of experimental & clinical cancer research : CR·2006
Thyroid metastases from colon cancer case report in a long term survivor.
Journal of experimental & clinical cancer research : CR·2006
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone.
Journal of chemotherapy (Florence, Italy)·2005
Frailty of older patients is not reflected in the melanoma tumor microenvironment and treatment response to immune checkpoint blockade therapy.
Journal for immunotherapy of cancer·2026
Pathogen-specific immune responses in Cornu aspersum maxima reveal hematopoietic activity of the hepatopancreas and innate lymphoid-like functions of hyalinocytes.
Developmental and comparative immunology·2026
NNV mediates the activation of the NLRP3 inflammasome through mtDNA release and oxidative DNA damage.
Fish & shellfish immunology·2026